Twist Bioscience (TWST) Research & Development (2017 - 2026)

Twist Bioscience (TWST) has reported Research & Development for 10 consecutive years, with $19.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Research & Development fell 17.65% year-over-year to $19.7 million; the TTM figure through Mar 2026 stood at $71.9 million (down 19.07% YoY), while the FY2025 annual figure was $80.3 million, down 11.63% from the prior year.
• Research & Development rose to $19.7 million in Q1 2026 per TWST's latest filing, from $17.1 million in the prior quarter.
• Across five years, Research & Development topped out at $36.8 million in Q2 2022 and bottomed at $17.0 million in Q3 2025.
• Historically, Research & Development has averaged $24.3 million across 5 years, with a median of $23.7 million in 2023.
• Annual changes were most pronounced in 2022 — Research & Development soared 97.78% — and 2023, when it plunged 33.42%.
• Twist Bioscience's Research & Development stood at $31.2 million in 2022, then decreased by 26.06% to $23.1 million in 2023, then decreased by 7.76% to $21.3 million in 2024, then dropped by 19.6% to $17.1 million in 2025, then advanced by 14.97% to $19.7 million in 2026.
• Business Quant data shows TWST's Research & Development at $19.7 million in Q1 2026, $17.1 million in Q4 2025, and $17.0 million in Q3 2025.